Buchumschlag

Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Huiguo Qing, Xiangyan Jiang, Yong Ma, Zongrui Xing, Yuxia Wu, Keshen Wang, Hongtai Cao, Zuoyi Jiao, Zeyuan Yu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Molecular Carcinogenesis
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A
von: Junhao Fu, et al.
Veröffentlicht: (2025)

SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocarcinoma Tumor Microenvironment
von: Yueze Liu, et al.
Veröffentlicht: (2025)

Differential Response and Resistance to KRAS‐Targeted Therapy
von: Zhaojin Liu, et al.
Veröffentlicht: (2025)

Harnessing Cuproptosis for Antitumor Immunity: A Review of Current Evidence and Therapeutic Strategies
von: Ivan Lu, et al.
Veröffentlicht: (2026)

Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy
von: Xing Ma, et al.
Veröffentlicht: (2024)

Targeting FGFR Attenuates Tumor Growth in an Anal Squamous Cell Carcinoma Patient Derived Xenograft Model
von: Thuc Ly, et al.
Veröffentlicht: (2025)

KDM6A Exhibits Antitumor Activities Toward Ovarian Cancer by Epigenetically Activating Transcription of ISG‐15
von: Caixia Han, et al.
Veröffentlicht: (2025)

miR‐150‐5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m6A Modification
von: Bin Zheng, et al.
Veröffentlicht: (2025)

microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2
von: Qing Xia, et al.
Veröffentlicht: (2024)

TSPAN31 Activates Fatty Acid Metabolism and PI3K/AKT Pathway to Promote Tumor Progression in Breast Cancer
von: Wenquan Luo, et al.
Veröffentlicht: (2025)

The 5‐Methylcytosine RNA Modification in Hepatitis B Virus‐Negative Hepatocellular Carcinoma: Insights From Long‐Read Nanopore Sequencing
von: Tianhan Sun, et al.
Veröffentlicht: (2026)

RUNX1 Directly Activates WNT2 to Orchestrate Tumor‐Associated Macrophage Reprogramming in Colorectal Cancer
von: Wei Sun, et al.
Veröffentlicht: (2026)

RNA m 5 C Modifications in the Development and Prognosis of Muscle‐Invasive Bladder Cancer
von: Lili Zhang, et al.
Veröffentlicht: (2025)

RNA Methyltransferase NSUN5 Promotes Esophageal Cancer via 5‐Methylcytosine Modification of METTL1
von: Yuanbo Cui, et al.
Veröffentlicht: (2024)

Integrated Analysis Reveals ZNF184 as a Novel Regulator of Stemness‐Associated Paclitaxel Resistance and Tumor Progression in Breast Cancer
von: Rong Gong, et al.
Veröffentlicht: (2026)

NSUN2 Promotes Prostate Cancer Cell Proliferation and Migration Through m5C Modifications of YES1
von: Tianming Chen, et al.
Veröffentlicht: (2025)

ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT‐GSK3β‐Snail Pathway
von: Xiaowen Ma, et al.
Veröffentlicht: (2024)

Lung Cancer Cells Secrete Glutamine to Accumulate Tumor‐Associated Macrophages
von: Joshua P. Reddy, et al.
Veröffentlicht: (2026)

Potential Crosstalk Between ANXA1+ Epithelial Cells and FABP4+ TAM Cells of Ferroptosis‐Related Molecular Clusters Promotes an Immunosuppressive Microenvironment in Non‐Small Cell Lung Cancer
von: Shengqiang Mao, et al.
Veröffentlicht: (2025)

Venetoclax Synergizes With Regorafenib for Colorectal Cancer by Targeting BCL‐2
von: Lijun Zhu, et al.
Veröffentlicht: (2025)

TRAF6 Exerts Tumor‐Promoting Effects via Genetic and Autophagic Modulation in Gastric Cancer
von: Yifan Zou, et al.
Veröffentlicht: (2025)

Long Non‐Coding RNA PTPRG‐AS1 Promotes Proliferation, Migration, and Invasion of Non‐Small Cell Lung Cancer Cells via Modulation of the IGF1/PI3K/AKT Signaling Pathway
von: Gongzhang Su, et al.
Veröffentlicht: (2026)

LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma
von: Yifan Wen, et al.
Veröffentlicht: (2026)

Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
von: Qun Chen, et al.
Veröffentlicht: (2024)

Identification of a Novel RUNX1::HMGN1 Fusion in Therapy Acute Myeloid Leukemia
von: Li Fen, et al.
Veröffentlicht: (2025)

M2 Macrophage‐Derived Exosomal circ_0088494 Inhibits Ferroptosis via Promoting H3K4me1 Modification of STEAP3 in Cutaneous Squamous Cell Carcinoma
von: Jun Yin, et al.
Veröffentlicht: (2024)

PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer
von: Yunyun Liu, et al.
Veröffentlicht: (2024)

Analysis of the Matrix Metalloproteinases Family Profile in Gastric Cancer Suggests Key Matrix Metalloproteinases for Tumor Development and Their Clinical Impact
von: Aline Costa Bastos, et al.
Veröffentlicht: (2026)

LKB1 Loss Sensitizes Lung Tumor Spheres to Mitomet‐Induced Ferroptosis, and These Effects are Enhanced by mTOR Inhibition
von: Xueqing Liang, et al.
Veröffentlicht: (2026)

EXPRESSION OF CONCERN: Combination Cisplatin and Sulforaphane Treatment Reduces Proliferation, Invasion, and Tumor Formation in Epidermal Squamous Cell Carcinoma
Veröffentlicht: (2024)

Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition
von: Fangquan Chen, et al.
Veröffentlicht: (2024)

Dynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population
von: Juliana Ramos Chaves, et al.
Veröffentlicht: (2026)

Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
von: Mengqiu Song, et al.
Veröffentlicht: (2024)

Therapeutic Targeting of the Pentose Phosphate Pathway in Colorectal Cancer Using 6‐Aminonicotinamide and 5‐Fluorouracil
von: Israa Ahmad Cheikh, et al.
Veröffentlicht: (2025)

Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical Model
von: Yuki Haga, et al.
Veröffentlicht: (2024)

Targeting TROP2 and Exploiting AUNIP as a Determinant of ADC Cytotoxicity and Chemosensitivity in HNSCC and ESCA Cancers
von: Jiaqi Bai, et al.
Veröffentlicht: (2026)

CYP4F11, an NRF2 Target Gene, Promotes Hepatocellular Carcinoma Cell Growth
von: Jinjing Chen, et al.
Veröffentlicht: (2025)

AN02, a Naovel Curcumin Derivative, Orchestrates APC‐SMAD4‐Mediated CTLA‐4 Degradation for Ovarian Cancer Therapy
von: Hairong Jin, et al.
Veröffentlicht: (2025)

RNF7‐Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes
von: Yiran Tao, et al.
Veröffentlicht: (2025)

KIAA1429 and AlkB Homolog 5 Regulate Bladder Cancer Progression via N6‐Methyladenosine‐Dependent Modulation of Sonic Hedgehog Signaling
von: Zhimin Jiao, et al.
Veröffentlicht: (2025)